LNTH vs PACS

LNTH exhibits strong operational health with a Piotroski F-Score of 7/9 and robust liquidity (Current Ratio 2.70), though it lacks an Altman Z-Score for bankruptcy benchmarking. While the company is highly profitable with an ROE of 21.45% and a consistent track record of earnings beats, the stock trades at a significant premium to its Graham Number ($35.98) and Intrinsic Value ($23.87). The bullish outlook is supported by a low Forward P/E of 12.81 and a positive analyst target of $91.38, but the current price is disconnected from deterministic value metrics.

PACS presents a high-growth profile tempered by significant financial leverage and mediocre fundamental health, as evidenced by a Piotroski F-Score of 4/9. While the stock trades near its growth-based intrinsic value ($35.99) and shows an attractive PEG ratio of 1.02, it is priced at a massive premium to its Graham Number ($12.88). Explosive earnings growth is offset by a poor track record of meeting analyst estimates and a high Debt/Equity ratio of 3.78. The divergence between 'Strong Buy' analyst ratings and bearish insider/technical signals suggests a period of volatility ahead.